Effects of ephrinB2 gene siRNA on the biological behavior of human colorectal cancer cells.

Abstract:

:Colorectal cancer (CRC) is a common gastrointestinal malignancy worldwide and is a lethal and aggressive malignancy with a dismal prognosis. EphrinB2 is a membrane-bound ligand and has an intracellular domain that also possesses an intrinsic signaling capacity called 'reverse signaling'. In the present study, CRC cell lines were screened for high expression of ephrinB2. Small interfering RNA (siRNA) knockdown of ephrinB2 was performed in human SW480 CRC cells. The levels of expression of ephrinB2, VEGF, CD105 and matrix metalloproteinase 9 (MMP9) protein were measured by western blotting, and messenger RNA (mRNA) levels were measured using real-time PCR. Apoptosis and cell cycle distribution were determined using flow cytometry. Cell proliferation was measured by a methyl thiazole tetrazolium (MTT) test and a scratch healing experiment was used to measure the extent of cell migration. A Transwell assay was used to detect the extent of cell invasion. The results showed that RNA interference (RNAi) of ephrinB2 effectively silenced the ephrinB2 gene at both the mRNA and protein levels in SW480 cells and inhibited the proliferation, invasion, migration and angiogenesis and induced apoptosis in SW480 cells. These effects may be attributed to VEGF and MMP9 regulation.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Li P,Chen W,Wang Y,Fu X,Wen K,Qian J,Huang C,Fu Z

doi

10.3892/or.2014.3633

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

758-66

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

33

pub_type

杂志文章
  • MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

    abstract::The aim of the present study was to investigate the role of miR‑203a‑3p in colorectal cancer (CRC) and identify the target gene of microRNA (miR)‑203a‑3p. A total of 59 sets of cancer tissues and corresponding adjacent non‑tumor tissues were collected from CRC patients (aged 31‑78 years) between October 2016 and May 2...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7310

    authors: Qian Z,Gong L,Mou Y,Han Y,Zheng S

    更新日期:2019-11-01 00:00:00

  • Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma.

    abstract::We investigated the microsatellite alterations in mitochondrial DNA (mtDNA) and in TP53 in thoracic esophageal squamous cell carcinomas (TESCC). Using laser microdissection, 66 paired non-cancerous esophageal muscles, non-cancerous esophageal mucosa, cancerous TESCC nests plus 35 metastatic lymph nodes harvested from ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1761

    authors: Lin CS,Wang LS,Chang SC,Chou TY,Hsu WH,Liu CS,Lee MH,Chung MY,Wei YH

    更新日期:2012-07-01 00:00:00

  • Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions.

    abstract::Erythropoietin (Epo) is a key regulator of erythroid cell proliferation, differentiation and apoptosis. In the form of the recombinant protein, it is widely used to treat various types of anemias, including that associated with cancer and with the myelosuppressive effects of chemotherapy, particularly platinum-based r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2566

    authors: Kriška J,Solár P,Varinská L,Solárová Z,Kimáková P,Mojžiš J,Fedoročko P,Sytkowski AJ

    更新日期:2013-09-01 00:00:00

  • A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.

    abstract::In a screen for thoracic malignancy-associated markers, thyroid stimulating hormone receptor (TSHR) was identified as a candidate as it binds to the previously-characterized lung cancer marker NKX2-1. We screened for mutations in all coding regions of the TSHR gene in 96 lung adenoc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1938

    authors: Kim JW,Lee S,Lui N,Choi H,Mulvihill M,Fang LT,Kang HC,Kwon YW,Jablons D,Kim IJ

    更新日期:2012-10-01 00:00:00

  • PDK1 inhibitor GSK2334470 synergizes with proteasome inhibitor MG‑132 in multiple myeloma cells by inhibiting full AKT activity and increasing nuclear accumulation of the PTEN protein.

    abstract::Phosphoinositide‑dependent kinase 1 (PDK1) is generally active in multiple myeloma (MM) and higher expression than other hematopoietic cells, which is associated with the drug resistance and the disease progression. Previous studies have demonstrated that PDK1 can be targeted therapeutically in MM. In the present stud...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6369

    authors: Zhang J,Yang C,Zhou F,Chen X

    更新日期:2018-06-01 00:00:00

  • In vivo real-time imaging of chemotherapy response on the liver metastatic tumor microenvironment using multiphoton microscopy.

    abstract::In vivo real-time visualization of chemotherapy response at the cellular level provides us with direct evidence of what happens on the tumor microenvironment of metastatic organs. We imaged the response of metastatic tumor cells and host stromal cells to chemotherapeutics on liver m...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1983

    authors: Tanaka K,Okigami M,Toiyama Y,Morimoto Y,Matsushita K,Kawamura M,Hashimoto K,Saigusa S,Okugawa Y,Inoue Y,Uchida K,Araki T,Mohri Y,Mizoguchi A,Kusunoki M

    更新日期:2012-11-01 00:00:00

  • Efficacy of oral UFT plus leucovorin therapy for colon cancer with ovarian and multiple liver metastases: report of two cases.

    abstract::Case 1: a patient was diagnosed as having ascending colon cancer with right ovarian metastasis, and underwent palliative right hemicolectomy plus oophorectomy. The tumor was a well-differentiated adenocarcinoma with right ovarian metastasis, and the disease was classified as stage IV. Oral chemotherapy with UFT plus L...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.5.1079

    authors: mukai M,Moriya H,Himeno S,Oida Y,mukohyama S,Nishi T,Nakasaki H,Satoh S,Makuuchi H

    更新日期:2001-09-01 00:00:00

  • Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity.

    abstract::Resolvins, an endogenous lipid mediator derived from eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) of fish oil, has been reported to have anti-inflammatory and antitumor effect in various pathogenic processes. However, there are no studies about the effects of resolvin D1 and E1 on concanavalin A-induced h...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4389

    authors: Kuang H,Hua X,Zhou J,Yang R

    更新日期:2016-01-01 00:00:00

  • microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.

    abstract::Formation of cancer stem cells (CSCs) and increased cells proliferation are involved in tumorigenesis, tumour recurrence and therapy resistance and microRNA is essential for the development of the biological traits of CSCs and the increased cells proliferation. Studying molecular mechanism of tumorigenesis, tumour rec...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5149

    authors: Liu Y,Miao L,Ni R,Zhang H,Li L,Wang X,Li X,Wang J

    更新日期:2016-12-01 00:00:00

  • Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations.

    abstract::Non-small cell lung cancer (NSCLC) patients with epithelial growth factor receptor (EGFR) mutations and bone metastases are often concurrently administered tyrosine kinase inhibitors (TKIs) and bisphosphonates. Yet, the effects and mechanisms of these agents are unclear. In the present study, we aimed to ascertain whe...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4741

    authors: Feng C,Liu X,Li X,Guo F,Huang C,Qin Q,Wang Y

    更新日期:2016-06-01 00:00:00

  • PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells.

    abstract::Glioblastoma (GBM) is the most common type of primary central nervous system tumor in adults, which has high mortality and morbidity rates, and short survival time, namely <15 months after the diagnosis and application of standard therapy, which includes surgery, radiation therapy and chemotherapy; thus, novel therape...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7472

    authors: Yang K,Tang XJ,Xu FF,Liu JH,Tan YQ,Gao L,Sun Q,Ding X,Liu BH,Chen QX

    更新日期:2020-03-01 00:00:00

  • The prognostic value of cadherin switch in bladder cancer.

    abstract::Loss of E-cadherin expression and gain of N-cadherin expression ('cadherin switch') is shown to be characteristic in epithelial to mesenchymal transition (EMT), a mechanism associated with cancer progression. Furthermore, the prognostic role of P-cadherin in different cancers is controversial. The aim of this study wa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000741

    authors: Jäger T,Becker M,Eisenhardt A,Tilki D,Tötsch M,Schmid KW,Romics I,Rübben H,Ergün S,Szarvas T

    更新日期:2010-04-01 00:00:00

  • Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience.

    abstract::Sunitinib is a novel, multi-targeted receptor tyrosine kinase inhibitor, which has demonstrated evidence of improved survival when compared to interferon (IFN)-alpha in patients with metastatic renal cell carcinoma (RCC). Recently published National Institute for Health and Clinical Excellence guidance recommends suni...

    journal_title:Oncology reports

    pub_type: 临床试验,杂志文章

    doi:10.3892/or_00000886

    authors: Ansari J,Fatima A,Fernando K,Collins S,James ND,Porfiri E

    更新日期:2010-08-01 00:00:00

  • miR-17-5p promotes the growth of osteosarcoma in a BRCC2-dependent mechanism.

    abstract::MicroRNA-17-5p has been proven upregulated in many human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma is still unclear. Thus, the aim of the present study was to explore the effects of miR-17-5p in osteosarcoma tumorigenesis and development. The ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4542

    authors: Wang W,Zhang L,Zheng K,Zhang X

    更新日期:2016-03-01 00:00:00

  • NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.

    abstract::Never in mitosis gene-A (NIMA)-related expressed kinase 2 (NEK2) has been recently reported to play a role in tumor progression, drug resistance and tumorigenesis. However, little is known about the effects of NEK2 in hepatocellular carcinoma (HCC) metastasis and the underlying mechanism. NEK2 expression levels were e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6224

    authors: Zhang Y,Wang W,Wang Y,Huang X,Zhang Z,Chen B,Xie W,Li S,Shen S,Peng B

    更新日期:2018-03-01 00:00:00

  • Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).

    abstract::Epithelial ovarian cancer (EOC) is the most common cause of gynecological cancer-related mortality. Clear cell EOC (cEOC) has a number of clinical features distinguishing it from other EOC because of frequent concurrence of endometriosis and highly chemoresistant nature resulting in a poor prognosis. Recent biochemica...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or_00000750

    authors: Kajihara H,Yamada Y,Kanayama S,Furukawa N,Noguchi T,Haruta S,Yoshida S,Sado T,Oi H,Kobayashi H

    更新日期:2010-05-01 00:00:00

  • Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.

    abstract::A small subset of cells within a malignant neoplasm, named cancer stem cells (CSCs) or tumour initiating cells, are thought to be capable of initiating the neoplasm itself, and of driving its growth and recurrence after treatment. It is unclear whether CSCs can be identified and experimentally induced within oral squa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1299

    authors: Qiao B,Johnson NW,Chen X,Li R,Tao Q,Gao J

    更新日期:2011-08-01 00:00:00

  • MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.

    abstract::Ovarian cancer (OC) is one of the most lethal gynecological malignancies in the world. The aim of the present study was to examine the role of microRNA (miR)-134-3p in OC. Reverse transcription-quantitative PCR was used to measure the expression levels of miR-134-3p. Cell Counting Kit-8, TUNEL, flow cytometric and col...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7844

    authors: Zhao M,Ji H,Fu Q,Cheng Q,Zhang Y,Yang Y

    更新日期:2021-01-01 00:00:00

  • Inhibition of xenograft human glioma tumor growth by lentivirus-mediated gene transfer of alphastatin.

    abstract::Angiogenesis is crucial for the development and metastasis of human brain glioma. Based on our previous successful construction of a lentivirus-mediated alphastatin (an endogenous angiogenesis inhibitor) gene transfer system and our findings that alphastatin exhibited potent inhibit...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2187

    authors: Che H,Song J,Guo S,Wang W,Gao G

    更新日期:2013-03-01 00:00:00

  • Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.

    abstract::In humans, four tropomyosin genes (TPM1, TPM2, TPM3, and TPM4) are known to produce a multitude of isoforms via alternate splicing and/or using alternate promoters. Expression of tropomyosin has been shown to be modulated at both the transcription and the translational levels. Tropomyosins are known to make up some of...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4732

    authors: Dube S,Thomas A,Abbott L,Benz P,Mitschow C,Dube DK,Poiesz BJ

    更新日期:2016-06-01 00:00:00

  • G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.

    abstract::Cisplatin (DDP), a cytotoxic antitumor drug, functions in a dose-dependent manner. However, the pursuit for high‑dose therapeutic effects leads to more serious side effects including kidney toxicity. Nephrotoxicity caused due to endothelial cell dysfunction and neutrophils infiltration in kidneys. Interleukin-8 (IL-8)...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3659

    authors: Li L,Khan MN,Li Q,Chen X,Wei J,Wang B,Cheng JW,Gordon JR,Li F

    更新日期:2015-02-01 00:00:00

  • Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.

    abstract::Thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) are considered to be key enzymes affecting the prognosis for patients with various cancers. We tried to prove the correlation of TP and DPD expression in hepatocellular carcinoma (HCC) and liver metastasis. We quantified TP and DPD levels by an enz...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hotta T,Kobayashi Y,Taniguchi K,Johata K,Sahara M,Watanabe T,Ochiai M,Tanimura H,Tsubota YT

    更新日期:2004-08-01 00:00:00

  • Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.

    abstract::Numerous studies have demonstrated that triptolide induces cell cycle arrest and apoptosis in human cancer cell lines. However, triptolide-induced DNA damage and inhibition of DNA repair gene expression in human skin cancer cells has not previously been reported. We sought the effects of triptolide on DNA damage and a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2170

    authors: Chueh FS,Chen YL,Hsu SC,Yang JS,Hsueh SC,Ji BC,Lu HF,Chung JG

    更新日期:2013-02-01 00:00:00

  • Synergistic antitumor effect of JAWSII dendritic cells and interleukin 12 in a melanoma mouse model.

    abstract::One of the possible ways to augment dendritic cell (DC) efficacy in presentation of tumor antigens to effector T cells is pulsing them with tumor-cell lysates and incubation with certain immunostimulators. We present the results of an immunotherapeutic approach in a murine B78-H1 mo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2193

    authors: Zapała Ł,Wolny R,Wachowska M,Jakóbisiak M,Lasek W

    更新日期:2013-03-01 00:00:00

  • Perillyl alcohol causes G1 arrest through p15(INK4b) and p21(WAF1/Cip1) induction.

    abstract::The monoterpene perillyl alcohol (POH) is a naturally occurring compound derived from citrus fruits, mint and herbs. It exhibited chemotherapeutic potential against various malignant tumors in preclinical models and is currently being tested in clinical trials in patients with refractory advanced cancers. POH inhibits...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2167

    authors: Koyama M,Sowa Y,Hitomi T,Iizumi Y,Watanabe M,Taniguchi T,Ichikawa M,Sakai T

    更新日期:2013-02-01 00:00:00

  • Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

    abstract::Patient survival in pancreatic cancer remains poor with gemcitabine (GEM)-based regimens. The target specific molecular agent lapatinib, a dual ErbB1 and ErbB2 receptor tyrosine kinase inhibitor, has shown significant activity against ErbB1 and ErbB2-expressing tumors. Since pancrea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2053

    authors: Singla S,Pippin JA,Drebin JA

    更新日期:2012-12-01 00:00:00

  • Quercetin acts as an antioxidant and downregulates CYP1A1 and CYP1B1 against DMBA-induced oxidative stress in mice.

    abstract::We investigated the effects of quercetin on 7,12-dimethylbenz(a)anthracene (DMBA)-induced oxidative stress and the expression of CYP1A1 and CYP1B1 in mice. Quercetin was administered orally to mice at 100 or 250 mg/kg BW for 18 days, after which DMBA (34 mg/kg BW) was administered intragastrically twice. Quercetin sho...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1753

    authors: Choi EJ,Kim T,Kim GH

    更新日期:2012-07-01 00:00:00

  • Loss of ONECUT1 expression in human pancreatic cancer cells.

    abstract::ONECUT1 (HNF-6) is the prototype of a new class of homeodomain transcription factors, that controls the development of pancreatic ducts during mouse development. In the present study, the role of ONECUT1 and its targeted genes TCF2, PKHD1 and CYS1 was analyzed in human pancreatic ductal adenocarcinoma (PDAC). mRNA lev...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jiang X,Zhang W,Kayed H,Zheng P,Giese NA,Friess H,Kleeff J

    更新日期:2008-01-01 00:00:00

  • Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.

    abstract::Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases is a promising cancer therapy. Experimental data demonstrate that these inhibitors in combination do not only show synergy in antitumor e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1086

    authors: De la Cruz-Hernández E,Perez-Plasencia C,Pérez-Cardenas E,Gonzalez-Fierro A,Trejo-Becerril C,Chávez-Blanco A,Taja-Chayeb L,Vidal S,Gutiérrez O,Dominguez GI,Trujillo JE,Duenas-González A

    更新日期:2011-02-01 00:00:00

  • MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.

    abstract::Colorectal cancer (CRC) is the most commonly diagnosed tumor worldwide. However, the molecular mechanisms and biological processes of CRC remain unknown. The present study used reverse transcription-quantitative polymerase chain reaction to determine the expression levels of microRNA (miR)-296 in CRC cell lines and ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6806

    authors: Zhang Z,Zhong X,Xiao Y,Chen C

    更新日期:2019-01-01 00:00:00